Riskpilot← Back to searchSign inGet full accessM Markevind AB
ABActiveOrg 5567993042Drottninggatan 9Medical specialists activities · NACE 8622Est. 20102 employees
Revenue 2024
SEK 3,4M
+15% vs 2023
EBITDA margin
7.9%
+292% vs 2023
Equity ratio
30.5%
Financial strength
Net profit 2024
SEK 207K
+20600% vs 2023
| Revenue | SEK 3,4M | +15% |
| EBITDA | SEK 267K | +292% |
| Net profit | SEK 207K | +20600% |
| Total assets | SEK 8,2M | -3% |
| Equity | SEK 2,5M | -12% |
| Employees | 2 | — |
Legal name
M Markevind AB
Org number
5567993042
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 januari 2010
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarmottagning, psykoterapi, handledning och undervisning inom psykiatri och sexologi samt bedriva coaching inom arbetsmarknadsområdet och utföra tjänster avseende marknadsföring samt därmed förenlig verksamhet.
Address
Drottninggatan 9
Email
marek@markevind.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 4 892 | 3 962 | 4 270 | 3 545 | 2 919 | 2 939 | 3 368 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 1 324 | 1 073 | 3 577 | 2 814 | 1 600 | 1 785 | 1 146 | −469 | −139 | 267 |
| Depreciation & amort. | −76 | −139 | −174 | −304 | −314 | −326 | −250 | −181 | −119 | −119 |
| EBIT | 1 248 | 934 | 3 403 | 2 510 | 1 286 | 1 459 | 896 | −650 | −258 | 148 |
| Net financials | −22 | −82 | −77 | −100 | −115 | −90 | −71 | −120 | −159 | −207 |
| Profit before tax | 921 | 675 | 2 518 | 1 770 | 904 | 1 137 | 867 | 20 | 20 | 280 |
| Tax | −205 | −152 | −558 | −396 | −199 | −250 | −189 | −20 | −19 | −73 |
| Net profit | 716 | 523 | 1 960 | 1 374 | 705 | 887 | 678 | 0 | 1 | 207 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 668 | 7 008 | 9 760 | 10 709 | 9 306 | 9 636 | 9 750 | 8 957 | 8 381 | 8 162 |
| Equity | 817 | 840 | 2 100 | 2 674 | 3 205 | 3 619 | 3 805 | 3 310 | 2 820 | 2 487 |
| Long-term debt | 4 694 | 4 350 | 4 230 | 2 310 | 690 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 560 | 1 043 | 1 847 | 3 503 | 2 921 | 3 294 | 3 263 | 3 756 | 4 107 | 4 559 |
| Total debt | 5 254 | 5 393 | 6 077 | 5 813 | 3 611 | 3 294 | 3 263 | 3 756 | 4 107 | 4 559 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20152024
Equity ratio
30.5%
This company
38.2%
Market median
+20% vs market
20152024
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
20152024
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
20152024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20152024
Debt / equity
2.28×
This company
0.62×
Market median
-268% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2020 | — | — | |
BA Auditor Substitute | Auditor Substitute | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of M Markevind AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingemar Torsten Kenneth Venemyr | Audit | 0 companies |
| Britt-Marie Agneta Lenz | Auditor Substitute | 0 companies |
| Maria Markevind | Board of Directors | 0 companies |
| Marek Markevind | Deputy Board Member | 0 companies |